Adding a hormone-suppressing shot to chemotherapy for some breast-cancer patients can reduce the risk of premature ovarian failure and increase the chances of fertility preservation—and potentially boost survival rates—according to a new study.. Such an option could help mitigate the effect of some breast-cancer drugs that can cause infertility or induce the menopause-like symptoms of premature ovarian failure in younger women, many of whom freeze their eggs or embryos before treatment if they want to have children. 